On October 19, Sunny Deol’s birthday, the actor’s latest project, Suryaa: Ant Se Aarambh Tak, was introduced with a digital teaser that promised another high‑octane action film. The promo, however, attracted the attention of the Indian Medical Association (IMA), which raised concerns over scenes that allegedly depicted violence against doctors.
According to a source speaking to Bollywood Hungama, the IMA’s complaint reached the Health Ministry and the makers of Suryaa have decided to postpone the film’s release. The source explained that the filmmakers do not intend to portray the medical profession negatively or encourage violence, but they must follow due process. They will obtain the necessary clearances, secure a censor certificate from the Central Board of Film Certification (CBFC), and then announce a new release date. The film is now expected to hit cinemas in 2027, with January 15 being a potential date, pending resolution of the issue.
The Times of India reported on October 23 that the IMA had written to the Ministry of Information & Broadcasting on October 22, urging an urgent review of the promotional material. The letter, addressed to Minister Ashwini Vaishnaw and copied to the Union Health and Home Ministries and the National Medical Commission chairperson, alleged that the promo generalized corruption in the medical field and portrayed violence against healthcare workers in a way that could erode public trust and endanger doctors’ safety. The IMA also called for a ban or other action if justified under applicable law.
In addition to the controversy surrounding Suryaa, Sunny Deol remains a busy actor in 2026. He is slated to appear in four releases that year: Border 2, Batwara 1947, Ramayana, and the Netflix original Ikka. In Ramayana, Deol makes a brief appearance as Lord Hanuman in the end credits, a cameo that still counts as part of his 2026 filmography.
While the delay of Suryaa to 2027 may disappoint fans, Deol’s packed schedule ensures that his presence will continue to dominate the Indian cinema landscape throughout 2026.










